Termination

Morningstar, Inc. Reports Fourth-Quarter, Full-Year 2023 Financial Results

Retrieved on: 
Thursday, February 22, 2024
Finance, Consulting, Banking, Professional Services, Asset Management, Carbon, Investment, Acquisition, Balance sheet, Managed account, Nextgen, Form 10-K, News, Morningstar, Inc., Growth, Investment management, AUM, Index, Table, ESG, AUMA, Supplement, PitchBook Data, GAAP, Termination, Security (finance), Writing, LCD, Workflow, Video game

Cash flows were impacted by items described in the Balance Sheet and Capital Allocation section totaling $90.8 million.

Key Points: 
  • Cash flows were impacted by items described in the Balance Sheet and Capital Allocation section totaling $90.8 million.
  • Adjusted operating income was $113.0 million in the fourth quarter of 2023, an increase of 70.2% compared with the prior-year period.
  • Free cash flow increased by 17.2% to $197.3 million for the full year 2023, compared with $168.3 million in the prior year.
  • Operating cash flow and free cash flow in 2023 were impacted by the termination of the Company's license agreement with Morningstar Japan K.K.

Guardian Capital Announces ETF Closures

Retrieved on: 
Friday, December 22, 2023
ETF, Finance Secretary (India), TSX, Toronto Stock Exchange, Capital, Termination, Security (finance)

TORONTO, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP (the “Manager”) today announced that it will terminate Guardian Fundamental All Country Equity ETF (TSX: GGAC) and Guardian Fundamental Emerging Markets Equity ETF (TSX: GGEM) (together, the “ETFs”) effective on or about March 15, 2024 (the “Termination Date”).

Key Points: 
  • TORONTO, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Guardian Capital LP (the “Manager”) today announced that it will terminate Guardian Fundamental All Country Equity ETF (TSX: GGAC) and Guardian Fundamental Emerging Markets Equity ETF (TSX: GGEM) (together, the “ETFs”) effective on or about March 15, 2024 (the “Termination Date”).
  • Unitholders may continue to buy or sell units of an ETF on any stock exchange on which the ETF is traded until the units are delisted.
  • Further details of the terminations will be mailed to unitholders of each ETF at least 60 days prior to the Termination Date.
  • For further information regarding the Guardian Capital ETFs, please visit www.guardiancapital.com/investmentsolutions.

ClimateRock Announces Termination of Business Combination Agreement

Retrieved on: 
Thursday, November 30, 2023
Combination, Business analyst, Termination, CLRC

that the Company has elected to terminate the Amended and Restated Business Combination Agreement among the Company, E.E.W.

Key Points: 
  • that the Company has elected to terminate the Amended and Restated Business Combination Agreement among the Company, E.E.W.
  • and the other parties thereto, dated as of August 3, 2023 (the “Business Combination Agreement”), effective immediately, pursuant to Section 9.1(b) and 9.2 thereof, since the conditions to the closing of the initial business combination were not satisfied or waived by the outside date of September 30, 2023 (the “Termination”).
  • As a result, the Business Combination Agreement is of no further force and effect, except for certain specified provisions in the Business Combination Agreement, which shall survive the Termination and remain in full force and effect in accordance with their respective terms.
  • The Company and its sponsor intend to seek alternative ways to consummate an initial business combination.

Industrial Tech Acquisitions II, Inc. Announces Termination of Merger Agreement with NEXT Renewable Fuels, Inc. and its Intention to Liquidate

Retrieved on: 
Wednesday, November 1, 2023
Transfer, Tax, Tripura Merger Agreement, Sponsor, Accounting, NEXT, Finance Secretary (India), Trust, Plan, Interest on Lawyer Trust Accounts, Termination, Charter, Agreement, Security (finance), Mergers and acquisitions

As a result, $165,137,380.09 (approximately $10.38 per share) was removed from the Trust Account to pay such holders, and the Company currently has 1,348,887 Public Shares outstanding.

Key Points: 
  • As a result, $165,137,380.09 (approximately $10.38 per share) was removed from the Trust Account to pay such holders, and the Company currently has 1,348,887 Public Shares outstanding.
  • The Merger Agreement was dated as of November 21, 2023, as amended.
  • The Termination and Release Agreement terminates the Merger Agreement on mutually acceptable terms.
  • The Termination and Release Agreement will be described in a Form 8-K to be filed by ITAQ.

Starton Therapeutics Announces Termination of Business Combination Agreement with Healthwell Acquisition Corp. I

Retrieved on: 
Friday, November 3, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Combination, Multiple myeloma, Lenalidomide, Safety, Termination, Therapy, Patient, Pharmaceutical industry

Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified Healthwell Acquisition Corp.

Key Points: 
  • Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, announced that it notified Healthwell Acquisition Corp.
  • I (NASDAQ: HWEL) (“Healthwell”) today that the Company had elected to terminate the business combination agreement among Starton, Healthwell and the other parties thereto dated as of April 27, 2023, as amended (the “Combination Agreement”), effective immediately.
  • The conditions to the closing of the initial business combination and subsequent amendments were not satisfied or waived by the outside date of November 3 2023 (the “Termination”).
  • “Over the last several months, Starton has taken significant, critical steps forward in its clinical development,” said Pedro Lichtinger, Chairman and CEO of Starton Therapeutics.

Integrated Wellness Acquisition Corp Announces Termination of Merger Agreement

Retrieved on: 
Wednesday, September 27, 2023
Agreement, Plan, Termination, Tripura Merger Agreement, NYSE, Airline, Mergers and acquisitions

NEW YORK, NY, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Integrated Wellness Acquisition Corp (NYSE: WEL) (the “Company”) announced that it notified Refreshing USA, LLC, that the Company had elected to terminate the Agreement and Plan of Merger among the parties, dated as of February 10, 2023 (the “Merger Agreement”), effective immediately, pursuant to Section 8.1(b) thereof, since the conditions to the closing of the initial business combination were not satisfied or waived by the outside date of July 31, 2023 (the “Termination”).

Key Points: 
  • NEW YORK, NY, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Integrated Wellness Acquisition Corp (NYSE: WEL) (the “Company”) announced that it notified Refreshing USA, LLC, that the Company had elected to terminate the Agreement and Plan of Merger among the parties, dated as of February 10, 2023 (the “Merger Agreement”), effective immediately, pursuant to Section 8.1(b) thereof, since the conditions to the closing of the initial business combination were not satisfied or waived by the outside date of July 31, 2023 (the “Termination”).
  • As a result, the Merger Agreement is of no further force and effect, with the exception of certain specified provisions in the Merger Agreement, which shall survive the Termination and remain in full force and effect in accordance with their respective terms.
  • The Company and its sponsor intend to seek alternative ways to consummate an initial business combination.

Apeiron Capital Investment Corp. Announces Termination of Business Combination Agreement and Liquidation

Retrieved on: 
Friday, August 11, 2023
Transfer, Tax, Business analyst, Termination, Finance Secretary (India), Combination, GIO, Security (finance)

BOSTON, MA , Aug. 11, 2023 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate the Business Combination Agreement between the parties, dated as of March 8, 2023 (as amended May 10, 2023, the “Business Combination Agreement”), pursuant to Section 8.1(b) thereof, effective as of August 14, 2023 (the “Termination”).

Key Points: 
  • BOSTON, MA , Aug. 11, 2023 (GLOBE NEWSWIRE) -- Apeiron Capital Investment Corp. (the “Company”) announced today that it has notified GIO World Health, Ltd. that the Company has elected to terminate the Business Combination Agreement between the parties, dated as of March 8, 2023 (as amended May 10, 2023, the “Business Combination Agreement”), pursuant to Section 8.1(b) thereof, effective as of August 14, 2023 (the “Termination”).
  • Upon the effectiveness of the Termination, the Business Combination Agreement will be of no further force and effect, with the exception of the specified provisions in Section 8.2 of the Business Combination Agreement, which shall survive the termination of the Business Combination Agreement and remain in full force and effect in accordance with their respective terms.
  • The redemption of the Public Shares is expected to be completed within ten business days after August 14, 2023.
  • There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

CONVENING NOTICE TO THE RECONVENED EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY

Retrieved on: 
Wednesday, July 12, 2023
Attention, Date, Amalgamation, EGM, Meeting, Article, Prospectus, Corporation, Termination, Proxy, Security (finance)

The quorum and the majority at the Meeting will be determined according to the shares issued by the Company and outstanding at midnight (Luxembourg time) on the fifth Luxembourg business day prior to the Meeting (the “Record Date”).

Key Points: 
  • The quorum and the majority at the Meeting will be determined according to the shares issued by the Company and outstanding at midnight (Luxembourg time) on the fifth Luxembourg business day prior to the Meeting (the “Record Date”).
  • If you wish to attend the EGM in person, please communicate to the Company your intention to us at the latest two business days before the Meeting.
  • The form(s) of proxy must be received by the Company at the latest two business days before the Meeting.
  • A copy of the updated Articles is available for inspection and can be obtained free of charge at the registered office of the Company.

CONVENING NOTICE TO THE RECONVENED EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY

Retrieved on: 
Wednesday, July 12, 2023
Attention, Date, Amalgamation, EGM, Meeting, Article, Prospectus, Corporation, Termination, Proxy, Security (finance)

The quorum and the majority at the Meeting will be determined according to the shares issued by the Company and outstanding at midnight (Luxembourg time) on the fifth Luxembourg business day prior to the Meeting (the “Record Date”).

Key Points: 
  • The quorum and the majority at the Meeting will be determined according to the shares issued by the Company and outstanding at midnight (Luxembourg time) on the fifth Luxembourg business day prior to the Meeting (the “Record Date”).
  • If you wish to attend the EGM in person, please communicate to the Company your intention to us at the latest two business days before the Meeting.
  • The form(s) of proxy must be received by the Company at the latest two business days before the Meeting.
  • A copy of the updated Articles is available for inspection and can be obtained free of charge at the registered office of the Company.

OSSIAM SHILLER BARCLAYS CAPE EUROPE SECTOR VALUE TR UCITS ETF: CONVENING NOTICE TO THE RECONVENED EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY

Retrieved on: 
Wednesday, July 12, 2023
Attention, Date, Amalgamation, EGM, Meeting, Article, Prospectus, OF, Company register, Corporation, Termination, Proxy, Security (finance)

OSSIAM SHILLER BARCLAYS CAPE EUROPE SECTOR VALUE TR UCITS ETF: CONVENING NOTICE TO THE RECONVENED EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY

Key Points: 
  • OSSIAM SHILLER BARCLAYS CAPE EUROPE SECTOR VALUE TR UCITS ETF: CONVENING NOTICE TO THE RECONVENED EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY
    Registered office: 49 Avenue J.F.
  • If you wish to attend the EGM in person, please communicate to the Company your intention to us at the latest two business days before the Meeting.
  • The form(s) of proxy must be received by the Company at the latest two business days before the Meeting.
  • A copy of the updated Articles is available for inspection and can be obtained free of charge at the registered office of the Company.